|
End-of-day quote
NSE India S.E.
2026-10-01
|
5-day change | 1st Jan Change | ||
| 931.00 INR | -2.03% |
|
-6.98% | +23.89% |
| 09-25 | Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| 08-14 | Supriya Lifescience Limited, Q1 2027 Earnings Call, Aug 14, 2026 |
Company Valuation: Supriya Lifescience Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 39,702 | 15,352 | 26,797 | 59,086 | 45,223 | 74,929 | - | - |
| Change | - | -61.33% | 74.55% | 120.5% | -23.46% | 65.69% | - | - |
| Enterprise Value (EV) | 39,702 | 15,352 | 26,797 | 59,086 | 45,223 | 74,929 | 74,929 | 74,929 |
| Change | - | -61.33% | 74.55% | 120.5% | -23.46% | 65.69% | 0% | 0% |
| P/E | 26.2x | 17.1x | 22.5x | 31.4x | 21.6x | 31.6x | 24x | 18.8x |
| PBR | - | - | - | - | 3.78x | 5.25x | 4.33x | 3.53x |
| PEG | - | -0.4x | 0.7x | 0.5x | 1.9x | 2.3x | 0.8x | 0.7x |
| Capitalization / Revenue | - | 3.33x | 4.7x | 8.48x | 5.46x | 7.54x | 6.03x | 4.83x |
| EV / Revenue | - | 0x | 0x | 0x | 0x | 7.54x | 6.03x | 4.83x |
| EV / EBITDA | - | 0x | 0x | 0x | 0x | 21.9x | 17x | 13.4x |
| EV / EBIT | - | - | 0x | 0x | 0x | 24.7x | 19.1x | 14.9x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 18.86 | 11.16 | 14.8 | 23.35 | 25.98 | 29.5 | 38.8 | 49.6 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | 4,609 | 5,704 | 6,965 | 8,279 | 9,935 | 12,418 | 15,523 |
| EBITDA 1 | - | 1,289 | 1,730 | 2,608 | 2,940 | 3,427 | 4,408 | 5,588 |
| EBIT 1 | - | - | 1,572 | 2,404 | 2,656 | 3,032 | 3,933 | 5,033 |
| Net income 1 | 1,518 | 898.6 | 1,191 | 1,880 | 2,091 | 2,372 | 3,122 | 3,993 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 493.30 | 190.75 | 332.95 | 734.15 | 561.90 | 931.00 | 931.00 | 931.00 |
| Nbr of stocks (in thousands) | 80,483 | 80,483 | 80,483 | 80,483 | 80,483 | 80,483 | - | - |
| Announcement Date | 5/20/22 | 5/26/23 | 5/28/24 | 5/27/25 | 5/27/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.21x | - | - | - | 798M | |
| 32.9x | 11.93x | 24.23x | 0.6% | 1,031B | |
| 29.45x | 6.54x | 18.31x | 2.02% | 638B | |
| 33.1x | 7.75x | 16.02x | 2.65% | 462B | |
| 105.72x | 5.91x | 25.05x | 2.35% | 359B | |
| 19x | 4.63x | 11.48x | 2.87% | 335B | |
| 20.37x | 5.28x | 13.08x | 3.03% | 273B | |
| 20.79x | 4.31x | 12.28x | 2.05% | 253B | |
| 26.62x | 6.92x | 12.32x | 2.39% | 228B | |
| -45.08x | 6.57x | 25.65x | 2.21% | 185B | |
| Average | 27.51x | 6.65x | 17.60x | 2.24% | 376.46B | |
| Weighted average by Cap. | 32.10x | 7.72x | 18.90x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SUPRIYA Stock
- Valuation Supriya Lifescience Limited
Select your edition
All financial news and data tailored to specific country editions
